PROTAC MDM2 Degrader-1 employs PROTAC technology to target and degrade MDM2. It consists of a potent MDM2 inhibitor linked to a ligand that interacts with E3 ubiquitin ligase, facilitating selective protein degradation. This structural design enhances the compound's ability to modulate protein levels effectively through targeted ubiquitination mechanisms. Reagent-grade; for laboratory research purposes only.
Usually ships within 24 hours.